1. Kilpi T, Peltola H, Jauhiainen T, Kallio MJ. Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. Pediatr Infect Dis J 1995;14:270-7.
2. Moon SY, Chung DR, Kim SW, Chang HH, Lee H, Jung DS, et al. Changing etiology of community-acquired bacterial meningitis in adults: a nationwide multicenter study in Korea. Eur J Clin Microbiol Infect Dis 2010;29:793-800.
3. Chaudhuri A, Martinez-Martin P, Kennedy P, Andrew Seaton R, Portegies P, et al. Bojar Medy PG, et al. EFNS Task Force. EFNS guideline on management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008;15:649-59.
4. Scheld WM, Whitley RJ, Marra CM. Infections of the central nervous system. Lippincott Williams & Wilkins; 2004.
5. Leib SL, Boscacci R, Gratzl O, Zimmerli W. Predictive value of cerebrospinal fluid (CSF) lactate level versus CSF/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis 1999;29:69-74.
7. Park JW, Chung SW, Ko SB, Choi YB, Lee KS. Predictive value of C-reactive protein in the differential diagnosis of acute meningitis in adults. J Korean Neurol Assoc 2003;21:248-54.
8. Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000;28:1828-32.
9. Choi SH, Kim YS, Bae IG, Chung JW, Lee MS, Kang JM, et al. The possible role of cerebrospinal fluid adenosine deaminase activity in the diagnosis of tuberculous meningitis in adults. Clin Neurol Neurosurg 2002;104:10-5.
10. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-84.
11. Kim MJ, Moon SM, Park TS, Suh J-T, Lee HJ. Clinical Aspects of Bacterial Meningitis in Cerebrospinal Fluid Culture Positive Patients in a Tertiary Care University Hospital. Korean J Clin Microbiol 2011;14:1-6.
12. Tunkel AR. Bacterial meningitis. Bookmantraa. com; 2001.
13. Kang MW. Central nervous system infections: practical application of the antimicrobial agents. J Korean Neurol Assoc 2004;22:95-101.
14. Maxson S, Lewno MJ, Schutze GE. Clinical usefulness of cerebrospinal fluid bacterial antigen studies. J Pediatr 1994;125:235-8.
15. Tarafdar K, Rao S, Recco RA, Zaman MM. Lack of sensitivity of the latex agglutination test to detect bacterial antigen in the cerebrospinal fluid of patients with culture-negative meningitis. Clin Infect Dis 2001;33:406-8.
16. Chiba N, Murayama SY, Morozumi M, Nakayama E, Okada T, Iwata S, et al. Rapid detection of eight causative pathogens for the diagnosis of bacterial meningitis by real-time PCR. J Infect Chemother 2009;15:92-8.
17. Steiner I, Schmutzhard E, Sellner J, Chaudhuri A, Kennedy P. EFNS‐ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system. Eur J Neurol 2012;19:1278-91.
18. Horwitz SJ, Boxerbaum B, O’Bell J. Cerebral herniation in bacterial meningitis in childhood. Ann Neurol 1980;7:524-8.
19. Korein J, Cravioto H, Leicach M. Reevaluation of lumbar puncture A study of 129 patients with papilledema or intracranial hypertension. Neurology 1959;9:290.
20. Gopal AK, Whitehouse JD, Simel DL, Corey GR. Cranial computed tomography before lumbar puncture: a prospective clinical evaluation. Arch Intern Med 1999;159:2681-5.
21. Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001;345:1727-33.
22. Chaudhuri A, Martin P, Kennedy P, Andrew Seaton R, Portegies P, Bojar M, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008;15:649-59.
23. Kamran S, Bener AB, Alper D, Bakshi R. Role of fluid-attenuated inversion recovery in the diagnosis of meningitis: comparison with contrast-enhanced magnetic resonance imaging. J Comput Assist Tomogr 2004;28:68-72.
24. Han KT, Choi DS, Ryoo JW, Cho JM, Jeon KN, Bae KS, et al. Diffusion-weighted MR imaging of pyogenic intraventricular empyema. Neuroradiology 2007;49:813-8.
25. Wong AM, Zimmerman RA, Simon EM, Pollock AN, Bilaniuk LT. Diffusion-weighted MR imaging of subdural empyemas in children. AJNR Am J Neuroradiol 2004;25:1016-21.
26. Kaplan SL. Management of pneumococcal meningitis. Pediatr Infect Dis J 2002;21:589-91.
28. Française Sdpidl. Practice guidelines for acute bacterial meningitidis (except newborn and nosocomial meningitis). Med Mal Infect 2009;39:356-67.
29. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998;129:862-9.
30. Proulx N, Frechette D, Toye B, Chan J, Kravcik S. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 2005;98:291-8.
31. Lepur D, Baršić B. Community-acquired bacterial meningitis in adults: antibiotic timing in disease course and outcome. Infection 2007;35:225-31.
34. The Korean Society of Infectious Diseases; The Korean Society for Chemotherapy; The Korean Neurological Association; The Korean Neurosurgical Society; The Korean Society of Clinical Microbiology. Clinical Practice Guidelines for the Management of Bacterial Meningitis in Adults in Korea. Infect Chemother 2012;44:140-63.
35. Böttcher T, Gerber J, Wellmer A, Smirnov AV, Fakhrjanali F, Mix E, et al. Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis. J Infect Dis 2000;181:2095-8.
36. Graninger W, Zeitlinger M. Clinical applications of levofloxacin for severe infections. Chemotherapy 2004;50:16-21.
37. Schmutzhard E, Williams K, Vukmirovits G, Chmelik V, Pfausler B, Featherstone A. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. J Antimicrob Chemother 1995;36:85-97.
38. Peltola H, Anttila M, Renkonen OV. Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Lancet 1989;333:1281-7.
39. Marks WA, Stutman HR, Marks MI, Abramson JS, Ayoub EM, Chartrand SA, et al. Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial. J Pediatr 1986;109:123-30.
40. Mylonakis E, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes: 33 years’ experience at a general hospital and review of 776 episodes from the literature. Medicine 1998;77:313-36.
41. Harder E, Møller K, Skinhøj P. Enterobacteriaceae meningitis in adults: a review of 20 consecutive cases 1977-97. Scand J Infect Dis 1999;31:287-91.
42. Brouwer MC, McIntyre P, de Gans J, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2010;(9):CD004405.
43. Moon S-Y, Chung DR, Kim S-W, Chang HH, Lee H, Jung DS, et al. Is adjunctive corticosteroid beneficial in pneumococcal meningitis in a region with high rates of resistance to penicillin and ceftriaxone? J Neurol 2012;259:1453-60.
44. Nadel S, Kroll JS. Diagnosis and management of meningococcal disease: the need for centralized care. FEMS Microbiol Rev 2007;31:71-83.
45. Wall EC, Ajdukiewicz K, Heyderman RS, Garner P. Osmotic therapies added to antibiotics for acute bacterial meningitis. Cochrane Database Syst Rev 2013;3:CD008806.
46. Chang CJ, Chang HW, Chang WN, Huang LT, Huang SC, Chang YC, et al. Seizures complicating infantile and childhood bacterial meningitis. Pediatr Neurol 2004;31:165-71.